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Abstract
Background The appropriate use of medicines is essential
for the provision of quality health services, patient safety,
and the rational use of health resources. In Sudan, general
practitioners (GPs) provide 80 % of insured patients’
health services. Pharmaceutical service costs have been
increasing since 2010.
Objectives We aimed to use the World Health Organiza-
tion (WHO) and International Network for the Rational
Use of Drugs prescribing indicators to assess prescription
quality among GPs in different types of primary healthcare
centers (PHCCs) within the National Health Insurance
Fund (NHIF) in Gezira State, Sudan.
Method We followed established WHO guidelines to
conduct a cross-sectional retrospective study. The study
was carried out over 6 months and involved 197 GPs with
valid prescriptions, representing 90 % of the total study
population of 220 GPs. We collected a systematic random
sample of 100 prescriptions for each GP and used Stata 12
to analyze the 19,700 prescriptions.
Results The mean ± standard deviation number of medi-
cations was 2.55 ± 1.32 per patient; 46.32 % of drugs
prescribed were generics; 54.71 % of prescriptions were
for antibiotics and 12.84 % were for injectable formula-
tions; and 81.19 % of prescribed medicines were from the
NHIF medicines list. The overall Index of Rational Drug
Prescribing (IRDP) indicator was 3.39, and the average
cost per prescription was 40.57 Sudanese pounds (SDG).
Disregarding prescriptions for antibiotics, the prescribing
quality of GPs in NHIF facilities was farther from optimal
prescribing practice than those in State Ministry of Health-
owned facilities and facilities owned by private groups,
universities, and non-governmental organizations.
Conclusion The present study provides strong evidence of
irrational prescribing practice among GPs, with significant
disparities, particularly in terms of antibiotic overuse,
generic drug underuse, and adherence to the NHIF
medicines list.
Key Points
A cross-sectional retrospective study was carried out
according to World Health Organization guidelines
over 6 months and included 197 general
practitioners (GPs) and 19,700 prescriptions.
This study revealed that the overall Index of Rational
Drug Prescribing (IRDP) indicator for GPs was
below the optimal prescribing practice level.
We found disparities in the IRDP between GPs at
different health facilities. GPs at National Insurance
Fund facilities scored lower than those at State
Ministry of Health facilities or other health facilities
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1 Introduction
The irrational use of medicines is a major problem
worldwide and represents the primary source of medical
waste and harm. The medicines component of the health
services package is more variable and dynamic than other
service components, particularly in terms of coverage,
quality, and cost. In recent years, the use of medicines has
increased in many countries [1]. The overuse of medicines
is diverse [1], and drug-prescribing indicators in develop-
ing countries are suboptimal, with core indicators varying
between countries. For instance, antibiotics and injecta-
bles are overused and generic medicines are underused in
Sudan [2]. The overuse of medicines not only leads to the
development of drug resistance and wastes resources but
also increases morbidity and mortality [3, 4]. Thus, the
appropriate use of medicines is an essential factor in the
provision of quality health services, patient safety, and the
rational use of health resources [5]. Low-quality prescrib-
ing is predominant in rural areas [6]. The World Health
Organization (WHO) and the International Network of
Rational Use of Drugs (INRUD) have developed widely
used core prescribing indicators to assess the prescribing
quality of primary healthcare facilities and to enable
comparisons between health facilities and prescribers [5].
To our knowledge, no prescriber-based study has been
conducted in Sudan; one study of the National Health
Insurance Fund (NHIF) has been conducted in health
facilities [7]. Previous studies have been based on the
facilities sampling method (Table 1) and have revealed
antibiotic overuse [8, 9], underuse of generic medicines,
and overprescribing of injectables [10]. Other studies have
revealed a relatively large average number of drugs per
prescription and poor adherence to the Essential Medicines
List (EML) [11]. These previous studies were conducted to
investigate prescription patterns; however, our study
investigated the prescribing practices of general practi-
tioners (GPs) and used the largest sample and a unique
study unit. We used prescribing indicators as a benchmark
among GPs at primary healthcare centers (PHCCs) and as a
baseline for regular assessment of prescribing quality [12].
In Sudan, GPs provide 80 % of insured patients’ health
services. Pharmaceutical service costs have been increasing
since 2010. The objective of this study was to use the
WHO/INRUD prescribing indicator to assess the quality of
prescribing among GPs at different types of PHCCs. We
used the assessment regimen created by WHO/INRUD to
evaluate prescribing performance according to the adopted
standards to monitor the improvement of rationality in
prescribing practice. Before rational prescribing can be
promoted, the prescribing practices of those who provide
80 % of the services must be ascertained.
2 Materials and Methods
The study was conducted in Gezira State, which represents
27 % of NHIF; we targeted all GPs (220) providing ser-
vices for NHIF subscribers at the primary healthcare level.
These GPs provide services at three types of health facil-
ities: (1) those owned by the NHIF, (2) those owned by the
State Ministry of Health (SMOH), and (3) those owned by
others (private interests, universities, and non-governmen-
tal organizations [NGOs]). Insured patients pay 25 % of
prescription costs, and pharmaceutical services are pro-
vided through a network of pharmacies owned by the
NHIF, SMOH, and others.
We collected 100 prescriptions for each GP according to
WHO/INRUD guidelines for comparisons between pre-
scribers [5]. The reference period of retrospective data
collection was 6 months, representing the last quarter of
2014 and the first quarter of 2015. Prescription collection
Table 1 Previous prescribing quality studies in Sudan










1991 [15] N. province PHCCs 1.4 63 63 36 –
1996 [8] Kh State PHCCs 1.9 48 73 22 98
1998 [16] Kh State Hospital and PHCCs 2.1 41 59 29 99
2004 [17] Kh State Teaching hospitals (2) 1.9 43 65 10.5 –
2007 [10] Six states PHCCs 2.3 44.6 66 27 73.5
2010 [9] Kh State PHCCs 2 43.2 71.8 13.7 92.7
2010 [18] Kh State Four pediatric hospitals 2 49.3 81.3 3.5 –
2012 [7] Five NHIF states PHCCs 2.6 54.2 64 14 99.3
2012 [11] Kh State Hospitals and pharmacies 2.8 37.3 54.3 38.6 72.8
EML Essential Medicines List, Kh State Khartoum State, N. Province Nile province, NHIF National Health Insurance Fund, PHCCs primary
healthcare centers
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was based on systematic random sampling, with an interval
determined by dividing the GP’s total prescriptions by 100.
Of the 220 GPs, 197 (90 %) had valid prescriptions over
the 6 months, and the total valid number of observations
was 19,700 prescriptions.
2.1 Data Analysis
Trained technical professionals collected the data. We used
the WHO/prescribing indicators investigation format [5].
Data were reviewed and entered twice in a Microsoft
Excel spreadsheet before being exported to Stata-12 for
analysis. The prescriptions data were transferred to WHO
investigation format, checked again for accuracy, entered
into an Excel sheet, and individually checked once more
for precision and completeness. We used the WHO/
INRUD standard method for calculating prescribing indi-
cators [5] (Table 2). The unit of analysis used was GP (100
prescriptions for each GP).
To determine prescribing rationality and quality at the GP
level, we used the Index of Rational Drug Prescribing
(IRDP) developed by Yuxin and Mingguang [14]. The IRDP
for each GP was calculated by compounding the indices of
the five prescribing indicators. The index of each prescribing
indicator was calculated by dividing the optimal value by the
achieved value for each GP. Moreover, for each type of
health facility, the IRDP was applied for comparison. The
overall prescribing indicators were calculated to determine
the GP’s prescribing pattern [6]. Finally, we analyzed
19,690 prescriptions from 197 GPs (10 invalid prescriptions
were excluded). Data at the GP level were clustered to
represent the three types of health facilities.
3 Results
The average number of medicines per prescription (2.55:
maximum 15, minimum 1) indicated a poly-pharmacy pat-
tern, with prescriptions involving antibiotics (54.71 %) and
injectable formulations (12.84 %). A total of 81.19 % of the
prescribed medicines were from the EML, and generics
accounted for 46.34 % of prescriptions, which is some dis-
tance from the optimal required level of 100 %. The average
cost per prescription was 40.57 Sudanese pounds (SDGs)
(Table 3). The prescribing indicators for all health facility
types were less than optimal. Values for NHIF facilities
were farther from the prescribing indicator standards than
were SMOH and other health facilities, except for the per-
centage of prescriptions containing antibiotics (NHIF 45.91
vs. SMOH 57.24 vs. others 56.84 %) (Table 3).
The correlation between GPs and IRDP was statistically
significant at p\ 0.001. The optimal index is 5; however,
the overall IRDP score for GPs was 3.39 (range 2.1–4.8).
The prescribing quality indices revealed that prescribing
practice was nowhere near the optimal index of 5, with
NHIF facilities having a lower index (3.08) than SMOH
facilities (3.46) and health facilities owned by others (3.75)
(Table 3).
4 Discussion
In NHIF Sudan, GPs provide 80 % of insured patients’
health services. Costs of pharmaceutical services have been
increasing since 2010. The objectives of this study were to
use the WHO/INRUD prescribing indicator to assess the
quality of prescribing among GPs at different types of
PHCCs. We conducted a cross-sectional retrospective
study over 6 months that involved 197 GPs with valid
prescriptions, representing 90 % of the total study popu-
lation (220). A systematic random sample of 100 pre-
scriptions was collected from each GP.
The study revealed that the mean number of medications
per prescription was 2.55 ± 1.32 drugs, which represents
poly-pharmacy according to the benchmark we applied of
more than two drugs [13]. The difference between GPs was
statistically significant at p\ 0.001. The mean number of
drug prescriptions was 2.55; this was much closer to the 2.6
found by a study conducted in NHIF facilities in 2012 in
five other states [7]. The mean number of drugs per pre-
scription was higher than most previously reported Suda-
nese studies when we excluded the studies by Mustafa [7]
Table 2 Adjusted prescribing
standards from WHO and
INRUD indicators
Prescribing indicators Optimal level Optimal IRDP
Mean medicines per prescription (whether or not drugs
dispensed)
\2 [13] 1
Medicines prescribed by generic name (%) 100 [5] 1
Prescriptions with an antibiotic (%) B30 [5] 1
Prescriptions with an injectable dosage form (%) B10 [5] 1
Medicines prescribed from NHIF GP’s medicines list (%) 100 1
Complementary indicator, average cost of prescription (SDG) 20.31 (proxy) –
INRUD International Network for the Rational Use of Drugs, IRDP Index of Rational Drug Prescribing,
NHIF National Health Insurance Fund, SDG Sudanese pound, WHO World Health Organization
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and Mahmoud et al. [11], who reported 2.6 and 2.8 drugs
per prescription, respectively (Table 1).When compared
with other developing countries, the mean number of drugs
per prescription in Sudan (2.55) was less than in Mali (3.2),
Yemen (3.0), Uganda (2.9), Thailand (2.85), and Pakistan
(2.7) [19–23]. However, GPs in Sudan prescribed a higher
mean number of drugs per prescription than those in India
(2.4), Tanzania (2.2), Saudi Arabia (2.08), and Malaysia
(2.0) [24–27]. Collectively, NHIF facilities had a higher
mean number of medications than other facilities
(Table 3). The major implications of poly-pharmacy are
additional avoidable costs and an increased probability of
adverse drug reactions. A limitation of the study was that
inter-country comparisons were not adjusted according to
the prevalence of chronic diseases in the population.
The percentage of generic medicines prescribed was
46.34 %, which is considerably lower than the standard of
100 %. The calculated percentage represents a severe
underuse of generic medicines that was also lower than the
Middle Eastern Mediterranean region’s average use of
generics (57.1 %) [28]. This result is consistent with pre-
vious studies conducted in different districts in Sudan
(Table 1). When compared with those of neighboring
countries, the percentage of generic drugs per prescription
in Sudan (46.34 %) was lower than in Egypt (95.4 %),
Ethiopia (99.16 %), Mali (70.4 %), Uganda (91.3 %), and
Yemen (67.1 %) [19–21, 29, 30]. However, the percentage
of generic drugs prescribed was remarkably higher in
Sudan than in Bahrain (14.3 %) and Jordan (5.1 %)
[29, 30]. GPs in NHIF facilities prescribed considerably
fewer generics (38.47 %) than those in SMOH (48.96 %)
and other facilities (49.28 %). The implications of low
generic use are primarily the wastage of scarce health
resources and a decrease in access to pharmaceuticals
because of an affordability barrier.
The percentage of prescriptions containing antibiotics
was 54.71 %, a considerably high result according to the
WHO guideline benchmark of B30 % antibiotic use. It was
consistent with percentages assessed previously in other
states of Sudan (Table 1). The percentage in the WHO
Eastern Mediterranean region was 53.6 %, slightly less
than found for Sudan in the current study [28]. The use of
antibiotics was lower in NHIF facilities (45.91 %) than in
SMOH (57.24 %) and other facilities (56.84 %). Antibiotic
overuse can have a devastating impact in terms of the
development of multi-drug-resistant bacteria, which can
lead to unmanageable infectious diseases.
The percentage of prescriptions containing injections
was 12.84 %, which is considered relatively over the
optimal level, although no strict standard exists, as the
WHO benchmark is \10 %. The average prevalence of
injection use in the Eastern Mediterranean Region is higher
(27.1 %) [28]. Studies conducted in Sudan reveal progress
in the rational use of injections (Table 1). This reduction is
attributable to a new malaria management protocol that
focuses strongly on ingestible formulations rather than
injection, which was the initial dominant medication
formulation.
The overall percentage of medications prescribed from
the EML was 81.19 %, whereas the prescribing quality
indicator standard is 100 %. EML adherence seems high;
however, in actuality, this figure is misleading because the
best achievement in core prescribing indicators was this
indicator worldwide. According to the WHO prescribing
database, on average, the Middle Eastern Mediterranean
region’s percentage of medicines prescribed from the EML
was 90.8 % [28]. Previous studies in Sudan have often
found this prescribing core indicator to be higher than
observed in this study (Table 1). Interestingly, we found
EML adherence was lower in NHIF facilities (72.65 %)
than in SMOH (82.97 %) and other facilities (89.27 %).
The study revealed overall IRDP to be 3.39, whereas the
standard is 5. A total of 197 GPs reported an IRDP of
2.1–4.88, which is relatively low compared with other
neighboring countries. For instance, ten health facilities in
Saudi Arabia reported an IRDP of 4.37–5 [12]. In Egypt,
the same processes were conducted in ten PHCCs and
revealed high IRDP rankings, ranging from 3.92 to 4.88
[31]. Although the IRDP was not high, it was higher than
the 3.32 reported in China [6]. The index values for NHIF
Table 3 Prescribing indicators
and health facility types
Type of health facility owner or operator SMOH NHIF Other Overall
Number of GPs 126 43 28 197
Average number of drugs per prescription 2.44 2.97 2.4 2.55
Medicines prescribed by generic name (%) 48.96 38.47 49.28 46.34
Prescriptions containing antibiotics (%) 57.24 45.91 56.84 54.71
Prescriptions containing injectable formulations (%) 12.55 15.58 9.97 12.84
Drugs prescribed from GP’s medicines list (%) 82.97 72.65 89.27 81.19
Average cost of prescription (SDGs) 36.07 59.54 31.69 40.57
IRDP 3.46 3.08 3.75 3.39
GP general practitioner, IRDP Index of Rational Drug Prescribing, NHIF National Health Insurance Fund,
SDG Sudanese pound, SMOH State Ministry of Health
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facilities (3.08) were lower than for SMOH (3.46) and
other (3.75) facilities (Table 3).
The current study revealed that the average prescription
cost was 40.57 SDG, almost double the proxy 20.31 SDG. A
study conducted in five states in 2012 reported an average
prescription cost of 20.5 SDG, almost half that observed in the
current study [7]. The primary cause of the cost increase is
attributed to the devaluation of the national currency, partic-
ularly over the last 4 years. When comparing average costs
with those in other countries, proper economic adjustment of
currency values is essential. Prescriptions from NHIF facili-
ties cost more than those from other facilities, with the average
prescription costing 59.54 SDG (NHIF), 36.07 (SMOH), and
31.69 SDG (other facilities). These disparities were attributed
to the relatively high percentage of patients with chronic
diseases in NHIF facilities (36 %), with SMOH facilities
having fewer such patients (18 %).
The authors consider the main cause of the observed sub-
optimal prescription quality to be low adherence to prescrib-
ing guidelines. NHIF facilities performed worse than other
facilities, which could be attributed to the accountability of
non-NHIF facilities (all services provided by these facilities
are reimbursed according to adherence to regulations), while
the NHIF facilities have not been subjected to that review.
5 Conclusion
Appropriate medicine use is essential to the provision of
quality health services, patient safety, and the rational use
of health resources. The present study used the largest
sample to date and a unique study unit to investigate pre-
scribing rationality among GPs at different types of health
facilities providing health services for insured patients in
Gezira State, Sudan. The study revealed that the overall
IRDP score for GPs was less than optimal and character-
ized by significant disparities between GPs at different
health facilities, with NHIF facilities receiving a lower
index. Further studies should be conducted to determine the
factors causing the considerable discrepancies (2.1–4.88
IRDP) between GPs at health facilities owned by the NHIF,
the SMOH, and others (private interests, universities, and
NGOs).
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